Ticker
LYRACompany Name
LYRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -38.82M | -5041.17% | $ 770K |
3/31/2025 | $ -79.5M | -6708.95% | $ 1.19M |
12/31/2024 | $ -93.4M | -6088.4% | $ 1.53M |
9/30/2024 | $ -97.56M | -6632.36% | $ 1.47M |
6/30/2024 | $ -101.33M | -5567.64% | $ 1.82M |
3/31/2024 | $ -68.82M | -4096.31% | $ 1.68M |
12/31/2023 | $ -62.62M | -4019.32% | $ 1.56M |
9/30/2023 | $ -61.7M | -4336.19% | $ 1.42M |
6/30/2023 | $ -60.84M | -4913.97% | $ 1.24M |
3/31/2023 | $ -59.59M | -4566.67% | $ 1.3M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for LYRA THERAPEUTICS INC is calculated as follows: EBIT [ $ -22.13M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]
Minimum
Sep 30, 2021
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |